These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11247101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of tardive dyskinesia with donepezil: a pilot study.
    Caroff SN, Campbell EC, Havey J, Sullivan KA, Mann SC, Gallop R.
    J Clin Psychiatry; 2001 Oct; 62(10):772-5. PubMed ID: 11816865
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tardive dyskinesia with quetiapine.
    Ghelber D, Belmaker RH.
    Am J Psychiatry; 1999 May; 156(5):796-7. PubMed ID: 10327920
    [No Abstract] [Full Text] [Related]

  • 7. Cholinergic-dopaminergic imbalance in Pisa syndrome.
    Villarejo A, Camacho A, García-Ramos R, Moreno T, Penas M, Juntas R, Ruiz J.
    Clin Neuropharmacol; 2003 May; 26(3):119-21. PubMed ID: 12782913
    [Abstract] [Full Text] [Related]

  • 8. Donepezil in schizophrenia--is it helpful? An experimental design case study.
    MacEwan GW, Ehmann TS, Khanbhai I, Wrixon C.
    Acta Psychiatr Scand; 2001 Dec; 104(6):469-72. PubMed ID: 11782241
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
    Stryjer R, Strous R, Bar F, Shaked G, Shiloh R, Rozencwaig S, Grupper D, Buchman N, Kotler M, Rabey JM, Weizman A.
    Hum Psychopharmacol; 2004 Jul; 19(5):343-6. PubMed ID: 15252826
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
    Keefe RS, Malhotra AK, Meltzer HY, Kane JM, Buchanan RW, Murthy A, Sovel M, Li C, Goldman R.
    Neuropsychopharmacology; 2008 May; 33(6):1217-28. PubMed ID: 17625502
    [Abstract] [Full Text] [Related]

  • 12. Can donepezil be considered a mild antipsychotic in dementia treatment? A report of donepezil use in 6 patients.
    Terao T, Shimomura T, Nakamura J.
    J Clin Psychiatry; 2003 Nov; 64(11):1392-3. PubMed ID: 14658957
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD.
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [Abstract] [Full Text] [Related]

  • 16. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV.
    J Clin Psychiatry; 2004 Feb; 65 Suppl 9():21-4. PubMed ID: 15189108
    [Abstract] [Full Text] [Related]

  • 17. [Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
    Formiga F, Fort I, Pérez-Castejón JM, Ruiz D, Duaso E, Riu S.
    Rev Clin Esp; 2006 Sep; 206(8):411-2; author reply 412-3. PubMed ID: 16863635
    [No Abstract] [Full Text] [Related]

  • 18. Donepezil for Down's syndrome.
    Kishnani PS, Spiridigliozzi GA, Heller JH, Sullivan JA, Doraiswamy PM, Krishnan KR.
    Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
    [No Abstract] [Full Text] [Related]

  • 19. Clinical forms of severe tardive dyskinesia.
    Gardos G, Cole JO, Salomon M, Schniebolk S.
    Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.